-
ENDRA Life Sciences Expands into China with Shanghai General Hospital Partnership
Jan 24, 2022
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced it has received Institutional Review Board approval from China’s renowned Shanghai Ge...read more > -
ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference
Jan 5, 2022
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, announces that management will present a company overview at the H.C. Wainwright BioConnect Virtual Con...read more > -
ENDRA Life Sciences Announces New Clinical Study Partnership with King’s College Hospital, London
Dec 13, 2021
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that King’s College Hospital, London (KCH) is now partnering with ENDRA for a clinica...read more > -
ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study
Nov 29, 2021
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), and VGI Health Technology Limited (NSX: VTL), a clinical-stage biotechnology company specializing ...read more > -
ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property with Issuance of 22nd and 23rd U.S. Patents
Nov 16, 2021
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent and Trademark Office has issued two patents, including U.S...read more > -
ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
Nov 15, 2021
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three months ended September 30, 2021 and provide...read more > -
ENDRA Life Sciences to Report Third Quarter 2021 Financial Results on November 15, 2021
Nov 8, 2021
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the third quarter of 2021 on Monday,...read more > -
ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property Protection with Issuance of 21st U.S. Patent
Oct 13, 2021
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), has recently been issued U.S. Patent 11147067 (the ‘067 patent) titled, “Method And System For...read more > -
ENDRA Life Sciences to Participate in the H.C. Wainwright 5th Annual NASH Investor Conference
Oct 5, 2021
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in the H.C. Wainwright 5th Annual NASH Investor Confere...read more > -
ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences
Sep 7, 2021
ANN ARBOR, MI / ACCESSWIRE / September 7, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in two u...read more >
